Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood-brain barrier integrity. (Q37894744)

From Wikidata

Jump to navigation Jump to search

scientific article published on 28 June 2011

Language	Label	Description	Also known as
English	Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood-brain barrier integrity.	scientific article published on 28 June 2011

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707463%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

Europe PubMed Central

Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood-brain barrier integrity (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707463%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

0 references

blood–brain barrier

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707463%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707463%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707463%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

5

object named as

Tomasz Gos

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707463%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Bernhard Bogerts

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707463%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Hans-Gert Bernstein

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707463%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Aye-Mu Myint

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707463%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

28 June 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707463%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

World Journal of Biological Psychiatry

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707463%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707463%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

482-492

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707463%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707463%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Impairment of the blood-brain barrier as an aetiological factor in paranoid psychosis.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Evidence for activation of microglia in patients with psychiatric illnesses.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

What is the blood-brain barrier (not)?

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

The mild encephalitis-hypothesis--new findings and studies

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Connectivity-based parcellation of human cingulate cortex and its relation to functional specialization.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Antibodies against cerebral M1 cholinergic muscarinic receptor from schizophrenic patients: molecular interaction

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Synthesis and release of neurotoxic kynurenine metabolites by human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Herpesviruses and Toxoplasma gondii in orbital frontal cortex of psychiatric patients

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Altered T-cell function in schizophrenia: a cellular model to investigate molecular disease mechanisms

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

From inflammation to sickness and depression: when the immune system subjugates the brain

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Neuroinflammation in schizophrenia-related psychosis: a PET study.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Absence of neurodegeneration in the thalamus and caudate of elderly patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

What is immune privilege (not)?

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Rheumatoid arthritis and schizophrenia: a negative association at a dimensional level

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Emerging role of glutamate in the pathophysiology of major depressive disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

The role of N-methyl-D-aspartate (NMDA) receptor-mediated neurotransmission in the pathophysiology and therapeutics of psychiatric syndromes.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Effects of antidepressants on the production of cytokines

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Quinolinate neurotoxicity in cortical cell culture.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Cytokine changes and tryptophan metabolites in medication-naïve and medication-free schizophrenic patients.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Cortical kynurenic acid bi-directionally modulates prefrontal glutamate levels as assessed by microdialysis and rapid electrochemistry

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Effects of ketamine in normal and schizophrenic volunteers

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Peripheral and cerebral metabolic abnormalities of the tryptophan-kynurenine pathway in a murine model of major depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Behavioral immunization: immunity to self-antigens contributes to psychological stress resilience

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Activation of P2X(7) receptors decreases glutamate uptake and glutamine synthetase activity in RBA-2 astrocytes via distinct mechanisms

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Sex-specific proteome differences in the anterior cingulate cortex of schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Depression and immunity: a role for T cells?

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Possible antipsychotic effects of minocycline in patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Antidepressant-like actions of minocycline combined with several glutamate antagonists

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Consensus paper of the WFSBP Task Force on Biological Markers: biological markers in depression.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

A psychoneuroimmunological perspective to Emil Kraepelins dichotomy: schizophrenia and major depression as inflammatory CNS disorders

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Cytokine–serotonin interaction through IDO: a neurodegeneration hypothesis of depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Th1, Th2, and Th3 cytokine alterations in major depression.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Association of seropositivity for influenza and coronaviruses with history of mood disorders and suicide attempts

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

NMDA receptor hypofunction model of schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Does minocycline have antidepressant effect?

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Receptor architecture of human cingulate cortex: evaluation of the four-region neurobiological model.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Anti-NMDA-receptor encephalitis. An interdisciplinary clinical picture

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Time course and localization patterns of interleukin-1beta messenger RNA expression in brain and pituitary after peripheral administration of lipopolysaccharide

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Cytokines sing the blues: inflammation and the pathogenesis of depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Gliogenesis and glial pathology in depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Decreased T cellular immune response in schizophrenic patients.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

The glossopharyngeal nerve as a novel pathway in immune-to-brain communication: relevance to neuroimmune surveillance of the oral cavity

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Curiosity to kill the KAT (kynurenine aminotransferase): structural insights into brain kynurenic acid synthesis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Toxoplasma gondii and schizophrenia: linkage through astrocyte-derived kynurenic acid?

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Increased cortical kynurenate content in schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Borna disease virus infection in psychiatric patients: are we on the right track?

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Breaching the blood-brain barrier as a gate to psychiatric disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Association study of IL10, IL1beta, and IL1RN and schizophrenia using tag SNPs from a comprehensive database: suggestive association with rs16944 at IL1beta.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Neuron-astrocyte signaling in the development and plasticity of neural circuits

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Glutamate and dopamine dysregulation in schizophrenia--a synthesis and selective review

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Endogenous kynurenines as targets for drug discovery and development

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Gadolinium-DTPA enhanced gradient echo magnetic resonance scans in first episode of psychosis and chronic schizophrenic patients

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Autoantibodies against four kinds of neurotransmitter receptors in psychiatric disorders.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Expression of CD40 in the brain of Alzheimer's disease and other neurological diseases

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Cytomegalovirus and schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Ultrastructural damage of capillaries in the neocortex in schizophrenia.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Cytokine signals propagate through the brain

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Cytokine hypothesis of schizophrenia pathogenesis: evidence from human studies and animal models

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Endothelial signaling in paracellular and transcellular leukocyte transmigration

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Allosteric modulation of NMDA receptor via elevation of brain glycine and D-serine: the therapeutic potentials for schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Disease-relevant autoantibodies in first episode schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

The relationship of depression and stressors to immunological assays: a meta-analytic review

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Kynurenine pathway in major depression: Evidence of impaired neuroprotection

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.583941

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37894744&oldid=1756756729"